Uchitani Yumi, Okuno Rumi, Ariyoshi Tsukasa, Kubota Hiroaki, Suzuki Jun, Sadamasu Kenji
Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, 169-0073, Japan.
Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, 169-0073, Japan.
J Infect Chemother. 2025 Jan;31(1):102484. doi: 10.1016/j.jiac.2024.07.024. Epub 2024 Jul 31.
Since the introduction of the national routine vaccination program against Streptococcus pneumoniae in Japan from the early 2010s, the incidence of invasive pneumococcal disease (IPD) caused by non-vaccine serotypes has increased. This study focused on non-vaccine serogroup 24 strains derived from IPD and aimed to clarify their genetic characteristics.
Between 2013 and 2022, 121 strains identified as serogroup 24 in patients with IPD were collected and applied to multilocus sequence typing and next-generation sequencing. Whole-genome data were used to delineate phylogenetic relationships and to identify virulence and antimicrobial resistance-associated genes.
Recent trends in sequence types (STs) were characterized by an increase in the proportion of ST162 and ST2754 for 24F and 24B, respectively, after 2018. Whole-genome phylogenetic analysis demonstrated that serogroup 24 strains were organized into three clades, closely related to STs but not with serotypes. All ST162 strains were classified as Global Pneumococcal Sequence Cluster (GPSC) 6 and harbored the virulence-associated rlrA islet, with co-trimoxazole-resistance mutations in folA and folP genes. Two ST162 strains with different serotypes 24F and 24B from the same patient were phylogenetically indistinguishable, showing that these strains were derived by serotype conversion during infection.
The recent changes in predominant STs were similar to those previously reported throughout Japan, except Tokyo. Little correlation between whole-genome phylogeny and serotypes and the observed serotype conversion in one patient indicate potentially variable immunogenicity of this serogroup.
自21世纪10年代初日本引入针对肺炎链球菌的国家常规疫苗接种计划以来,由非疫苗血清型引起的侵袭性肺炎球菌病(IPD)的发病率有所上升。本研究聚焦于源自IPD的非疫苗血清群24菌株,旨在阐明其遗传特征。
在2013年至2022年期间,收集了121株在IPD患者中鉴定为血清群24的菌株,并应用于多位点序列分型和下一代测序。全基因组数据用于描绘系统发育关系,并鉴定毒力和抗微生物耐药相关基因。
序列类型(STs)的近期趋势表现为,2018年后,24F的ST162和24B的ST2754比例分别增加。全基因组系统发育分析表明,血清群24菌株分为三个进化枝,与STs密切相关,但与血清型无关。所有ST162菌株均归类为全球肺炎球菌序列簇(GPSC)6,并携带毒力相关的rlrA小岛,folA和folP基因存在复方新诺明耐药突变。来自同一患者的两株不同血清型24F和24B的ST162菌株在系统发育上无法区分,表明这些菌株是在感染期间通过血清型转换产生的。
除东京外,主要STs的近期变化与此前在日本全国报道的情况相似。全基因组系统发育与血清型之间几乎没有相关性,且在一名患者中观察到血清型转换,这表明该血清群的免疫原性可能存在差异。